(Press-News.org) BOSTON--By "distracting" cancer proteins from their usual activity, scientists at Dana-Farber Cancer Institute and Brigham and Women's Hospital have caused cells in a rare, lethal form of cancer to begin behaving like normal cells -- one of the longest-standing, and most rarely achieved, goals of cancer research. The study's findings are published online by the journal Cancer Research and will appear later in a print issue.
When the approach was tested in a child with an advanced case of the malignancy, known as NUT midline carcinoma (NMC), it slowed the course of the disease for several months. That result, in a cancer for which there are no other effective treatments, is a powerful impetus for making the new therapy available to patients in clinical trials, the authors assert.
"NUT midline carcinoma arises people of all ages, but predominantly in children and young adults," explained the study's senior co-author, James Bradner, MD, of Dana-Farber. "It usually originates in the chest, sometimes in the head or neck, and is often mistaken for other types of cancer. Traditional therapy involves surgery, radiation, and chemotherapy, but even in combination these approaches don't work well: most patients live only about nine and a half months after diagnosis. As we've learned more about the molecular basis of the disease, we've begun to be able to devise therapies against it."
The cause of the disease was discovered by Christopher French, MD, a senior author of the study from Brigham and Women's Hospital. It results from a "translocation" in which two genes from different chromosomes stick together and give rise to an abnormal, fused protein called BRD4-NUT. While Bradner and his colleagues have subsequently developed and studied compounds that target BRD4-NUT directly, the newly published study involves a more oblique approach.
Researchers discovered that BRD4-NUT causes cells to become cancerous by attaching to DNA's packing material within the nucleus -- a band of proteins known as histones, part of the machinery for switching genes on and off. BRD4-NUT essentially locks down the machinery's control panel, preventing changes that allow cells to develop into mature, stable, slow-growing adults, leaving them in a state of perpetual, hyperactive youth.
To interfere with BRD4-NUT's affinity for histones, French and Bradner tried a diversionary tactic. They treated NMC cells with a substance called an HDAC (histone deacetylase) inhibitor, which creates competing binding sites for BRD4-NUT throughout the nucleus. The hope was that, like a burglar who bypasses one house for the promise of a bigger prize in another, the HDAC inhibitor would lure BRD4-NUT away from certain locations in the genome.
In laboratory experiments, they found that NMC cells treated with an HDAC inhibitor turned into ordinary, non-dividing skin cells -- a process known as "differentiation," which has been a central goal of cancer research for well over half a century. In studies with animals engrafted with NMC tissue, animals treated with HDAC inhibitors had slower-growing tumors and lived longer than those who were not treated.
"These findings provided convincing evidence that we've uncovered a key mechanism by which BRD4-NUT prevents cell differentiation," said Bradner. The results established the rationale for the first, prospective clinical trial of the HDAC inhibitor in a single patient with NMC. A Food and Drug Administration-approved inhibitor was prescribed to a child suffering from extensive NMC, leading to positive results after five weeks of therapy: PET scans showed the tumor was markedly less active than at the start of therapy. Although the patient eventually succumbed to the disease, the response to the drug heartened investigators on the potential of this approach. Dana-Farber's Chief of Staff, Stephen Sallan, MD, co-led the clinical study.
The inspiration for this approach came from earlier research by French. About five years ago, he was investigating the effect of HDAC inhibitors on cell memory -- the ability of cells to "remember" the type of cell they are as they divide. "HDAC inhibitors can alter cell memory," French explained. "We hypothesized that treating NMC cells with these inhibitors would change the cells' memory and modify their identity. What happened was that the cells remembered what type of cell they initially were and switched back to being normal skin-like cells. BRD4-NUT, it turns out, interferes with cell memory. Blocking the protein with HDAC inhibitors restores that memory."
The discovery remained an interesting scientific "epiphany," French said, until he met Bradner, sparking the idea of using it as the basis for a potential treatment for NMC. According to French, the new study marks the first time scientists have therapeutically caused a carcinoma -- a cancer of cells lining an organ or tissue -- to differentiate.
"The inhibitor used in the patient described in this study was a first-generation agent, and we're optimistic that future versions will be both more effective and easier for patients to tolerate," Bradner said. "To our knowledge, this study represents the first time a targeted drug has demonstrated anti-cancer activity against this devastating tumor. The same approach may prove beneficial against other cancers as well."
INFORMATION:
The paper's first author is Brian Schwartz, PhD, formerly a postdoctoral fellow at Brigham and Women's. In addition to Bradner, French and Sallan, the other authors are Matthias Hofer, MD, Michael Cameron, Tan Ince, MD, PhD, Jon Aster, MD, PhD, and Elin Agoston, PhD, Brigham and Women's; Amanda Christie, Katherine Janeway, MD, Madeleine Lemieux, PhD, and Andrew Kung, MD, PhD, Dana-Farber; Daniel Bauer, MD, PhD, Sara Vargas, MD, and Antonio Perez-Atayde, MD, Children's Hospital Boston; Nathan West, Harvard Medical School; and Nicolas Reynoird, PhD, and Saadi Khochbin, PhD, Institut National de la Sante et de la Recherche Medicale, Grenoble, France.
The study was funded by a Nodal Research Award from the Dana-Farber/Harvard Cancer Center.
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Children's Hospital Boston as Dana-Farber/Children's Hospital Cancer Center. Dana-Farber is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.
Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. BWH is the home of the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 900 physician-investigators and renowned biomedical scientists and faculty supported by more than $ 537 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit www.brighamandwomens.org.
Scientists devise targeted therapy strategy for rare form of childhood cancer
2011-03-30
ELSE PRESS RELEASES FROM THIS DATE:
Elderly heart failure patients who need skilled nursing care often sicker, have poorer outcomes
2011-03-30
Elderly patients with heart failure who need skilled nursing care after hospital discharge are often sicker, at higher risk for poor outcomes and are more likely than other patients to die or be rehospitalized within one year, according to research reported in Circulation: Heart Failure, an American Heart Association journal.
"Patients hospitalized with heart failure are high risk to start with," said Larry A. Allen, M.D., M.H.S., lead author of the study and assistant professor of cardiology at the University of Colorado-Denver School of Medicine in Aurora. "If they ...
Moderate sleep and less stress may help with weight loss
2011-03-30
(PORTLAND, Ore.) March 29, 2011— If you want to increase your chances of losing weight, reduce your stress level and get adequate sleep. A new Kaiser Permanente study found that people trying to lose at least 10 pounds were more likely to reach that goal if they had lower stress levels and slept more than six hours but not more than eight hours a night.
The paper, published today in the International Journal of Obesity, was the result of a study funded by the National Institutes of Health's National Center for Complementary and Alternative Medicine.
Nearly 500 participants ...
Major report shows obese patients have double the risk of airway problems during an anesthetic
2011-03-30
A major UK study on complications of anaesthesia has shown that obese patients are twice as likely to develop serious airway problems during a general anaesthetic than non-obese patients. 'The airway' means the air passages from the outside world to the lungs, which must be kept open to keep the patient alive. The study also shows that the use of a simple breathing monitor, called a capnograph, could significantly reduce deaths and brain damage from such problems in intensive care units (ICUs); it found that absence of a capnograph contributed to 74% of deaths from these ...
Diabetes veterans may show ways to prevent complications
2011-03-30
BOSTON – March 29, 2011 – Over time, diabetes can wreak havoc on the body's eyes, cardiovascular system, kidneys and nerves. A major study by Joslin Diabetes Center researchers, however, has found that some people who have survived diabetes for many decades exhibit remarkably few complications—a discovery that points toward the presence of protective factors that guard against the disease's effects.
The scientists studied 351 participants in the Joslin 50-Year Medalist study, which examines people who have lived with type 1 diabetes for 50 years or more. Among this population, ...
UAB research targets way to stop brain tumor cell invasion
2011-03-30
BIRMINGHAM, Ala., - Gliomas are brain invaders. A kind of malignant tumor cell, gliomas branch out like tendrils from a central tumor source, spreading cancer throughout the brain. Traditional therapies, such as cutting out the tumor surgically, can be ineffective if the cells have already spread. Researchers at the University of Alabama at Birmingham may have come upon a way to stop a glioma invasion in its tracks, using a drug already approved for use in Europe.
Much like early explorers of the Old West followed rivers and streams, depending on them to provide drinking ...
Mothers abused during childhood at risk for having low birth weight babies
2011-03-30
Mothers who were maltreated as children have increased risk for giving birth to low birth weight babies. The findings, by researchers at the University of Washington, are the first to show that maternal maltreatment can affect the health of offspring.
The study also finds that childhood poverty and substance use during adolescence and pregnancy contribute to low birth weight, which is linked to infant mortality and chronic health problems.
"Our findings suggest that a mother's economic position in childhood and her experience of maltreatment during childhood have implications ...
Babies who sleep with smoker parents exhibit high nicotine levels
2011-03-30
"Third-hand smoke" stuck to skin or clothing is responsible for the high nicotine levels seen in babies who share a bedroom with their smoker parents. This is the conclusion of a study carried out in Catalonia, which also shows that ventilating bedrooms is not effective in reducing the levels of toxins from passive smoking.
"Passive smoking is the leading preventable cause of childhood death in developed countries", Guadalupe Ortega, lead author of the research study and coordinator of the Atenció Primària Sense Fum programme at the Department of Health of the Generalitat ...
MedWOW Upgrades Sales Leads Program
2011-03-30
MedWOW.com, the multilingual, global online marketplace for medical equipment, announces the launch of their upgraded sales leads program. All of the business leads generated are pre-qualified, registered buyers, looking for services and devices the merchants are offering. More than 10,500 medical equipment professionals visit the MedWOW site daily and transactions occur quickly and on a regular basis, so leads are kept fresh and current.
When purchasing leads credits, dealers now have the option of choosing money-saving discounted packages. The larger the package of ...
Free phone app helped doctors perform better in simulated cardiac emergency
2011-03-30
Doctors who used a free iPhone application provided by the UK Resuscitation Council performed significantly better in a simulated medical emergency than those who did not, according to a study in the April issue of Anaesthesia.
"Every year approximately 30,000 people in the UK have an unexpected cardiac arrest in hospital and, despite significant advances in resuscitation research, survival rates for adults suffering a cardiac arrest remain poor" says Dr Daniel Low, the consultant anaesthetist who developed the application.
"More than 60,000 free copies of the iResus ...
Spiders target sexy signals from 'vibrating' insects
2011-03-30
Insects using vibration to attract a mate are at risk of being eaten alive by killer spiders, Cardiff University scientists have discovered.
Studying spider behaviour experts from Cardiff University's School of Biosciences found that the vibrations used by leafhoppers and many other insects to attract a mate can be intercepted and used by predatory spiders to identify their prey.
Predators are already known to exploit the sight, sound and smell communications of their prey – but this is the first time that scientists believe they have discovered predators such as ...